Christopher Paul Simms's most recent trade in 4D Molecular Therapeutics Inc was a trade of 219,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Christopher Paul Simms | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 219,000 | 219,000 | - | - | Stock Option (Right to Buy) |